Applied Dna Sciences (APDN) 4.31 $APDN
Applied DNA Sciences Acquires Assets of DNA Manufacturer Vandalia Research
Marketwired - Fri Sep 11, 12:29PM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping services and product authentication solutions, announced that it has acquired the assets of privately held Vandalia Research, Inc. for $1.5 million in cash.
APDN: 4.31 (+0.36)
Applied DNA Sciences and MSS Professional A/S Sign Agreement to Distribute SmokeCloak(R) DNA Fog Security Solutions
Marketwired - Thu Sep 10, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today a new three year worldwide agreement with partner MSS Professional A/S for the exclusive supply of SigNature®DNA for use in the unique SmokeCloak® DNA security fog system.
APDN: 4.31 (+0.36)
Applied DNA Sciences Reaches Conviction Milestone
Marketwired - Wed Sep 09, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today that the number of CViT convictions attributed to the use of SigNature(®) DNA in cash boxes has risen to 101 with prison sentences of over 470 years. SigNature DNA forensic markers are helping the police to identify stolen cash and to link the evidence directly to the perpetrators.
APDN: 4.31 (+0.36)
Applied DNA Sciences and Techmer PM Announce Technology Partnership
Marketwired - Tue Sep 08, 4:30AM CDT
Applied DNA Sciences, Inc., (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain, and product authentication solutions, and Techmer PM (Twitter: @TechmerPM), a leading producer of value-added colors and additives for the plastics and fiber industries, announced a partnership that applies DNA tagging to fiber applications.
APDN: 4.31 (+0.36)
Applied DNA Sciences Achieves ISO/IEC 17025:2005 Accreditation
Marketwired - Tue Sep 01, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today that it has achieved ISO/IEC 17025:2005 Accreditation for the Examination and Analysis of CViT (cash and valuables in transit) and Asset Protection products, utilizing Fragment Length Polymorphism from ANSI-ASQ National Accreditation Board (ANAB).
APDN: 4.31 (+0.36)
Applied DNA Sciences Signs Contract With Fifth Federal Agency
Marketwired - Tue Aug 18, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has entered into a two-year contract with another U.S. government agency. Terms of the contract, including the scope of services, are confidential.
APDN: 4.31 (+0.36)
Applied DNA Sciences Fiscal Third-Quarter Revenues Increase 170% Year over Year
Marketwired - Mon Aug 10, 4:00PM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced results of its third quarter of fiscal 2015.
APDN: 4.31 (+0.36)
Applied DNA Sciences Schedules Fiscal Third Quarter Webcast for August 11, 2015 at 9:00 AM EDT
Marketwired - Mon Aug 03, 9:14AM CDT
Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, will host a conference call on Tuesday, August 11, 2015 at 9:00 AM EDT to discuss its fiscal third quarter results. The Quarterly Report Form 10Q will be filed with the SEC by the end of the day on Monday, August 10, 2015, and the press release will be issued prior to the call.
APDN: 4.31 (+0.36)
Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025 - Authentication Technologies & Track & Trace Technologies
M2 - Thu Jul 23, 9:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3pbvf6/pharmaceutical) has announced the addition of the "Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025" report to their offering. The Pharmaceutical Anti-Counterfeiting Technologies, 2015-2025' report provides a comprehensive study of the growing market of anti-counterfeiting technologies being used in the pharmaceutical industry. This study provides extensive details on technologies which offer overt and covert features to enable verification of drugs. In addition, it reviews the different track and trace technologies which enable tracking of a product through the supply chain. Counterfeiting of products is a big concern in several industries such as electronics, cosmetics, tobacco, wine & spirits and fast moving consumer goods. Specifically, within the pharmaceutical market, the magnitude of the problem is relatively high as it has a direct impact on the health of the wider community. It is worth highlighting that the pharmaceutical market is highly attractive for counterfeiters due to several benefits such as high price of patented drugs, lack of proper legislations and high demand of medicines compared to their supply. The primary goal of anti-counterfeiting technologies is to prevent counterfeiting of products; this is done by making it difficult to copy patent protected drugs as well as preventing entry of substandard or fake drugs into the product supply chain. The market can be categorised into two segments, Authentication Technologies (the technologies providing overt and covert security features) and Track & Trace Technologies (the technologies facilitating visibility of products throughout the supply chain). Specifically in the Authentication segment, technologies providing covert security features are very popular and occupy a major share in of the overall authentication market. These technologies are very difficult to mimic and require special instruments / devices for verification of drugs by the manufacturers. Managing supply chain, especially in case of pharmaceutical industry, is a big challenge. Pharmaceuticals supply chains are highly complex and therefore make it an ideal target for counterfeiters. However, recently many developments have taken place to overcome this challenge. Several countries across the globe have passed legislations, making it mandatory to implement serialisation by the manufacturers. Serialisation is being thought as a one stop solution to prevent counterfeiting in the pharmaceutical industry by securing the supply chain. The field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. The overall interest continues to rise as is evident from the number of counterfeit incidents and various laws and legislations being passed throughout the world. Small companies that have developed anti-counterfeiting technologies are likely to play a very active role in the near future. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Authentication: Key Players and Technologies 6. Track And Trace: Key Technologies and the Concept of Serialisation 7. Market Forecast 8. SWOT Analysis 9. Interview Transcripts 10. Conclusion 11. Appendix 1: Tabulated Data 12. Appendix 2: Companies and Organisations Listed Companies Mentioned - 35 of the 125 Companies Featured - 3M - 3S Simons Security Systems - ACG-Worldwide - Acsis - Alcan Packaging - Alien Technology - Alliance for Safe Online Pharmacies - AlpVision - Amcor - Amgen - Applied DNA Sciences - Atlantic Zeiser - Authentix - Avery Dennison - Axway - Ball Packaging - Bilcaretech - Biocode - Bosch Packaging Technology - Canadadrugs.com - Catalent Pharma - Cellular Bioengineering - Central Anti-Counterfeiting Laboratory - Chesapeake (Acquired by The Carlyle Group) - Cognizant - Confidex - Coresonant - Covectra - Deutsche Welle - DiNova Venture Capital - DNA Technologies - Dupont - Eli Lilly and Company - EM Microelectronics - European Alliance of Access to Safe Medicines For more information visit http://www.researchandmarkets.com/research/3p...maceutical
APDN: 4.31 (+0.36), AMGN: 153.21 (+0.07), LLY: 81.80 (+0.96)
SNS FiRe Conference Names Applied DNA Sciences a 2015 FiReStarter Company
Marketwired - Tue Jul 07, 8:04AM CDT
Strategic News Service (SNS) has selected Applied DNA Sciences, a biotechnology firm that provides DNA-based authentication and security solutions and services, as a 2015 FiReStarter company to be featured at the 13th annual Future in Review (FiRe) conference. FiRe 2015 will take place October 6-9, 2015, at the Stein Eriksen Lodge Deer Valley in Park City, Utah.
APDN: 4.31 (+0.36)
Applied DNA Sciences Acquires Assets of DNA Manufacturer Vandalia Research
Marketwired - Fri Sep 11, 12:29PM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping services and product authentication solutions, announced that it has acquired the assets of privately held Vandalia Research, Inc. for $1.5 million in cash.
APDN: 4.31 (+0.36)
Applied DNA Sciences and MSS Professional A/S Sign Agreement to Distribute SmokeCloak(R) DNA Fog Security Solutions
Marketwired - Thu Sep 10, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today a new three year worldwide agreement with partner MSS Professional A/S for the exclusive supply of SigNature®DNA for use in the unique SmokeCloak® DNA security fog system.
APDN: 4.31 (+0.36)
Applied DNA Sciences Reaches Conviction Milestone
Marketwired - Wed Sep 09, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today that the number of CViT convictions attributed to the use of SigNature(®) DNA in cash boxes has risen to 101 with prison sentences of over 470 years. SigNature DNA forensic markers are helping the police to identify stolen cash and to link the evidence directly to the perpetrators.
APDN: 4.31 (+0.36)
Applied DNA Sciences and Techmer PM Announce Technology Partnership
Marketwired - Tue Sep 08, 4:30AM CDT
Applied DNA Sciences, Inc., (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain, and product authentication solutions, and Techmer PM (Twitter: @TechmerPM), a leading producer of value-added colors and additives for the plastics and fiber industries, announced a partnership that applies DNA tagging to fiber applications.
APDN: 4.31 (+0.36)
Applied DNA Sciences Achieves ISO/IEC 17025:2005 Accreditation
Marketwired - Tue Sep 01, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, product genotyping and product authentication solutions, announced today that it has achieved ISO/IEC 17025:2005 Accreditation for the Examination and Analysis of CViT (cash and valuables in transit) and Asset Protection products, utilizing Fragment Length Polymorphism from ANSI-ASQ National Accreditation Board (ANAB).
APDN: 4.31 (+0.36)
Applied DNA Sciences Signs Contract With Fifth Federal Agency
Marketwired - Tue Aug 18, 4:30AM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that it has entered into a two-year contract with another U.S. government agency. Terms of the contract, including the scope of services, are confidential.
APDN: 4.31 (+0.36)
Applied DNA Sciences Fiscal Third-Quarter Revenues Increase 170% Year over Year
Marketwired - Mon Aug 10, 4:00PM CDT
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced results of its third quarter of fiscal 2015.
APDN: 4.31 (+0.36)
Applied DNA Sciences Schedules Fiscal Third Quarter Webcast for August 11, 2015 at 9:00 AM EDT
Marketwired - Mon Aug 03, 9:14AM CDT
Applied DNA Sciences (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, will host a conference call on Tuesday, August 11, 2015 at 9:00 AM EDT to discuss its fiscal third quarter results. The Quarterly Report Form 10Q will be filed with the SEC by the end of the day on Monday, August 10, 2015, and the press release will be issued prior to the call.
APDN: 4.31 (+0.36)
Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025 - Authentication Technologies & Track & Trace Technologies
M2 - Thu Jul 23, 9:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3pbvf6/pharmaceutical) has announced the addition of the "Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025" report to their offering. The Pharmaceutical Anti-Counterfeiting Technologies, 2015-2025' report provides a comprehensive study of the growing market of anti-counterfeiting technologies being used in the pharmaceutical industry. This study provides extensive details on technologies which offer overt and covert features to enable verification of drugs. In addition, it reviews the different track and trace technologies which enable tracking of a product through the supply chain. Counterfeiting of products is a big concern in several industries such as electronics, cosmetics, tobacco, wine & spirits and fast moving consumer goods. Specifically, within the pharmaceutical market, the magnitude of the problem is relatively high as it has a direct impact on the health of the wider community. It is worth highlighting that the pharmaceutical market is highly attractive for counterfeiters due to several benefits such as high price of patented drugs, lack of proper legislations and high demand of medicines compared to their supply. The primary goal of anti-counterfeiting technologies is to prevent counterfeiting of products; this is done by making it difficult to copy patent protected drugs as well as preventing entry of substandard or fake drugs into the product supply chain. The market can be categorised into two segments, Authentication Technologies (the technologies providing overt and covert security features) and Track & Trace Technologies (the technologies facilitating visibility of products throughout the supply chain). Specifically in the Authentication segment, technologies providing covert security features are very popular and occupy a major share in of the overall authentication market. These technologies are very difficult to mimic and require special instruments / devices for verification of drugs by the manufacturers. Managing supply chain, especially in case of pharmaceutical industry, is a big challenge. Pharmaceuticals supply chains are highly complex and therefore make it an ideal target for counterfeiters. However, recently many developments have taken place to overcome this challenge. Several countries across the globe have passed legislations, making it mandatory to implement serialisation by the manufacturers. Serialisation is being thought as a one stop solution to prevent counterfeiting in the pharmaceutical industry by securing the supply chain. The field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. The overall interest continues to rise as is evident from the number of counterfeit incidents and various laws and legislations being passed throughout the world. Small companies that have developed anti-counterfeiting technologies are likely to play a very active role in the near future. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction 4. Market Overview 5. Authentication: Key Players and Technologies 6. Track And Trace: Key Technologies and the Concept of Serialisation 7. Market Forecast 8. SWOT Analysis 9. Interview Transcripts 10. Conclusion 11. Appendix 1: Tabulated Data 12. Appendix 2: Companies and Organisations Listed Companies Mentioned - 35 of the 125 Companies Featured - 3M - 3S Simons Security Systems - ACG-Worldwide - Acsis - Alcan Packaging - Alien Technology - Alliance for Safe Online Pharmacies - AlpVision - Amcor - Amgen - Applied DNA Sciences - Atlantic Zeiser - Authentix - Avery Dennison - Axway - Ball Packaging - Bilcaretech - Biocode - Bosch Packaging Technology - Canadadrugs.com - Catalent Pharma - Cellular Bioengineering - Central Anti-Counterfeiting Laboratory - Chesapeake (Acquired by The Carlyle Group) - Cognizant - Confidex - Coresonant - Covectra - Deutsche Welle - DiNova Venture Capital - DNA Technologies - Dupont - Eli Lilly and Company - EM Microelectronics - European Alliance of Access to Safe Medicines For more information visit http://www.researchandmarkets.com/research/3p...maceutical
APDN: 4.31 (+0.36), AMGN: 153.21 (+0.07), LLY: 81.80 (+0.96)
SNS FiRe Conference Names Applied DNA Sciences a 2015 FiReStarter Company
Marketwired - Tue Jul 07, 8:04AM CDT
Strategic News Service (SNS) has selected Applied DNA Sciences, a biotechnology firm that provides DNA-based authentication and security solutions and services, as a 2015 FiReStarter company to be featured at the 13th annual Future in Review (FiRe) conference. FiRe 2015 will take place October 6-9, 2015, at the Stein Eriksen Lodge Deer Valley in Park City, Utah.
APDN: 4.31 (+0.36)
